1. Home
  2. IVVD vs NEN Comparison

IVVD vs NEN Comparison

Compare IVVD & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

N/A

Current Price

$0.46

Market Cap

212.6M

Sector

Health Care

ML Signal

N/A

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

SELL

Current Price

$45.95

Market Cap

197.0M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
IVVD
NEN
Founded
2020
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
212.6M
197.0M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
IVVD
NEN
Price
$0.46
$45.95
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 3.4M
949.0
Earning Date
11-16-2026
03-12-2027
Dividend Yield
N/A
★ 3.48%
EPS Growth
★ 79.02
N/A
EPS
N/A
★ N/A
Revenue
$53,426,000.00
★ $89,196,544.00
Revenue This Year
$12.92
N/A
Revenue Next Year
$44.18
N/A
P/E Ratio
★ N/A
$19.68
Revenue Growth
★ 110.47
N/A
52 Week Low
$0.49
$43.00
52 Week High
$3.01
$69.25

Technical Indicators

Market Signals
Indicator
IVVD
NEN
Relative Strength Index (RSI) 30.94 43.67
Support Level N/A N/A
Resistance Level $0.66 $66.30
Average True Range (ATR) 0.05 0.58
MACD -0.01 0.05
Stochastic Oscillator 5.08 42.14

Price Performance

Historical Comparison
IVVD
NEN

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

Share on Social Networks: